TagAustralian Federation of AIDS Organisations (AFAO)

HIV in Australia 2021: infographics

H

AFAO, December 1st, 2020 Each year, AFAO develops the ‘HIV in Australia’ summary of the latest key HIV data and stats. The latest summary has just been released. Key points: Rapid uptake of PrEP, in combination with treatment as prevention, has led to declines in HIV notifications among Australian-born gay and bisexual men. Across the last six years, there has been a 44% decrease in HIV...

Information about TRUVADA and ATRIPLA delisting

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know

C

CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...

The Ban on ‘Amyl’

T

Thorne Harbour Health, 17 Jan 2019 Australia’s Therapeutic Goods Administration (TGA) recently postponed its decision on whether or not to change the law around alkyl nitrites (the active ingredient in ‘amyl’ or ‘poppers’). Currently, the TGA is conducting public consultations into the proposed amendments that could see amyl recategorised as a ‘prohibited...

Gonorrhoea: Drug Resistance in Australia

G

Australian Federation of AIDS Organisations (AFAO), 26 June 2018 There has long been concern globally about the potential emergence of drug resistant STIs. In response, the World Health Organisation released new treatment guidelines for three common STIs – chlamydia, gonorrhoea and syphilis – in 2016. At present, strains resistant to first line treatment of syphilis and chlamydia are not common...

HIV PrEP available on PBS in Australia from 1 April / Links to Clinical Resources

H

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), 21 March 2018 ASHM congratulates the Federal Health Minister, the Hon. Greg Hunt’s announcement of a landmark in HIV prevention to approve HIV-prevention drugs – tenofovir with emtricitabine, known as PrEP – on the Pharmaceutical Benefits Scheme from 1 April, thereby providing broader access for any doctor or general...

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories